Top Markets
Coin of the day
Spago Nanomedical AB (publ) Spago Nanomedical AB (publ)

Spago Nanomedical AB (publ)

SPAGO
Pozycja w akcjach #32285
Operating primarily in Sweden, Spago Nanomedical AB (publ) is dedicated to... Operating primarily in Sweden, Spago Nanomedical AB (publ) is dedicated to pioneering nanomedicines for both the diagnosis and treatment of cancer. The company is actively pursuing two key projects: the SpagoPix initiative, centered on SN132D, a gadolinium-free MRI contrast agent developed for imaging breast and pancreatic cancers; and the Tumorad project, which is advancing SN201, a radionuclide therapy intended for managing advanced and metastatic forms of cancer. Originally established as Spago Imaging AB (publ), the company adopted its current name, Spago Nanomedical AB (publ), in May 2014. Founded in 1999, its base of operations is situated in Lund, Sweden.
Cena akcji
$0.01317984
Ostatnia synchronizacja: 2026-08-17
Kapitalizacja rynkowa
$10.52M
Zmiana (1 dzień)
-1.26%
Zmiana (1 rok)
-53.51%
Kraj
SE
Handel Spago Nanomedical AB (publ) (SPAGO)

Kategoria

Historia ceny akcji dla Spago Nanomedical AB (publ) (SPAGO)
Najwyższa cena zamknięcia: $0.01 dnia 2026-08-01

Najniższa cena zamknięcia: $1.82 dnia 2013-01-01
Historia cen akcji firmy Spago Nanomedical AB (publ) od 2013 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 49.55%
2025 -31.97%
2024 -41.92%
2023 -54.33%
2022 -87.66%
2021 -49.08%
2020 -37.41%
2019 30.59%
2018 14.03%
2017 -24.70%
2016 -12.65%
2015 29.84%
2014 -30.41%
2013 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$515.58 32.24%
US
$992.01 50.00%
NL
$111.17 -36.90%
AU
$736.64 6.99%
CH
$1.06K -6.61%
KR